It is the first test kit for COVID-19 that can be self-administered by citizens at home, in India. This indigenous test kit will be distributed through to 95% of the PIN codes in the county and will be available over-the-counter at pharmacies and drugstores across India. Individuals can also order it online through India’s homegrown e-commerce marketplace, Flipkart. To ensure safe deliveries, Flipkart also offers contactless payments for consumers and will leverage its safe and sanitized supply chain. The company will roll out 1 million self-test kits starting today and based on consumer demand, it will make 7 million units available per week. The product should be available in retail within 2-3 days. The company plans to make the products available on the Government e-marketplace (GEM).

Priced at INR 250, CoviSelfTM offers a comfortable, easy-to-use and accurate alternative to the current test method. It can be used by individuals with or without symptoms and immediate contacts of confirmed cases as per the ICMR guidelines. Designed as the mid-nasal swab test, it can detect positive results in just 15 mins. Each unit contains a testing kit, instructions to use (IFU) leaflet and a bag to safely dispose of after testing.

Speaking on this landmark milestone, Hasmukh Rawal, Managing Director of Mylab Discovery Solutions said, “Self-testing should slow down the spread of COVID-19 significantly. We aim to make CoviSelfTM available across the length and breadth of the country, especially for the people residing in rural areas who have limited options for testing.”

The second wave of COVID-19 pandemic has had a huge impact on people, institutions and systems in the country. It is critical to undertake efficient, mass testing to not only contain the spread of the virus but also to safeguard the healthcare infrastructure from extreme strain. The list of authorized dealers of CoviSelfTM is available on https://coviself.com/where-to-buy/.